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Abstract
Background: Over the past decade, pathway and gene-set enrichment analysis has evolved into the study of
high-throughput functional genomics. Owing to poorly annotated and incomplete pathway data, researchers have
begun to combine pathway and gene-set enrichment analysis as well as network module-based approaches to
identify crucial relationships between different molecular mechanisms.
Methods: To meet the new challenge of molecular phenotype discovery, in this work, we have developed an
integrated online database, the Pathway And Gene Enrichment Database (PAGED), to enable comprehensive
searches for disease-specific pathways, gene signatures, microRNA targets, and network modules by integrating
gene-set-based prior knowledge as molecular patterns from multiple levels: the genome, transcriptome, post-
transcriptome, and proteome.
Results: The online database we developed, PAGED http://bio.informatics.iupui.edu/PAGED is by far the most
comprehensive public compilation of gene sets. In its current release, PAGED contains a total of 25,242 gene sets,
61,413 genes, 20 organisms, and 1,275,560 records from five major categories. Beyond its size, the advantage of
PAGED lies in the explorations of relationships between gene sets as gene-set association networks (GSANs). Using
colorectal cancer expression data analysis as a case study, we demonstrate how to query this database resource to
discover crucial pathways, gene signatures, and gene network modules specific to colorectal cancer functional
genomics.
Conclusions: This integrated online database lays a foundation for developing tools beyond third-generation
pathway analysis approaches on for discovering molecular phenotypes, especially for disease-associated pathway/
gene-set enrichment analysis.
Background
Pathway analysis and gene-set enrichment analysis are
both widely-used methods to identify significant mole-
cular expression patterns from high-throughput data [1].
Over the last decade, biological pathways have provided
natural sources of molecular mechanisms to develop
diagnosis, treatment, and prevention strategies for com-
plex diseases [2-4]. The various and massive functional
genomics data are effectively analyzed by gene-set
enrichment methods instead of individual gene analysis
[5-8]. Pathway analysis and molecular signature discov-
ery continue to reveal the association between genotypes
and phenotypes, which are simply called molecular pro-
filing or molecular phenotypes. At present, researchers
intend to combine pathway and gene-set enrichment
approaches and network module-based approaches to
* Correspondence: wanping@mail.cnu.edu.cn; jakechen@iupui.edu
† Contributed equally
1School of Informatics, Indiana University, Indianapolis, IN 46202, USA
4Capital Normal University, Beijing, 100048, China
Full list of author information is available at the end of the article
Huang et al. BMC Bioinformatics 2012, 13(Suppl 15):S2
http://www.biomedcentral.com/1471-2105/13/S15/S2
© 2012 Huang et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
identify crucial relationships among different molecular
mechanisms [1].
As sources of prior knowledge for molecular mechan-
isms, biological pathway databases are heterogeneous,
cross multiple levels, and lack annotations [3]. Different
pathway databases may yield divergent results from the
same input data. When different databases yield similar
results, applying multiple pathway data sources in a single
analysis can generate a measure of validation. Unlike can-
didate pathway analysis, genome-wide pathway analysis
does not require prior biological knowledge. In addition,
genome-wide pathway analysis can reveal gene interac-
tions across different diseases [3,9] and multiple pathways
[3,10,11]. Other studies based on an online integrated
human pathway database (HPD) also provided associations
between different pathways with diverse types, sizes, and
sources [12,13] on specific phenotypes. Although these
efforts have greatly improved the efficiency of pathway
analysis, our knowledge of biological pathways is still far
from complete.
Gene signature data from the transcriptome level offers
a complementary source of information to complete
pathway knowledge. In a recent review, Khatri et al. [1]
categorized pathway analysis into three generations of
approaches: the first-generation “over-representation
analysis” (ORA) approaches, the second-generation
“functional class scoring” (FCS) approaches, and the
third-generation “pathway topology” (PT) approaches. To
overcome the limitations of ORA approaches (gene-level
statistics), FCS approaches, such as gene-set enrichment
analysis (GSEA) [6], were devised to include overall
changes of gene expressions in each pathway/gene set
(pathway-level statistics). Third generation approaches
also include overall changes of gene expressions based on
pathway topology–that is, their upstream/downstream
positions within each pathway. Although these third gen-
eration approaches were meant to change our under-
standing of the underlying mechanisms of pathways, they
lack information necessary to achieve this: the interde-
pendence between pathways. Annotated knowledge from
genome, transcriptome, post-transcriptome, and pro-
teome levels can assist pathway and gene-set enrichment
analysis.
Multi-level, multi-scale, knowledge-guided enrichment
analysis can enable molecular phenotype discovery for
specific human diseases. Currently, the acquisition of
prior knowledge and systems modeling poses a challenge
for developing tools that go beyond third-generation
pathway analysis for disease-specific molecular profiling.
Prior knowledge acquisition requires attention to updates
and improves the available annotations with descriptive
knowledge from multiple levels, especially for informa-
tion on pathway microenvironment (“condition-, tissue-,
and cell-specific functions of each gene”) [1,3]. Systems
biology modeling must incorporate data from the view of
systems biology to build systems with multiple scales,
which can be used to generate hypotheses that will give
detailed and accurate predictions of changes in systems.
Both aspects of this challenge will be addressed by build-
ing a database not only containing disease-associated
genes, transcript factors, proteins, and microRNAs, but
also by organizing their relationships within and between
pathways, gene signatures, and any gene sets from exist-
ing experiments or papers.
To meet the new challenges of molecular phenotype
discovery, we developed in this work an integrated
online database, the Pathway And Gene Enrichment
Database (PAGED), to enable comprehensive searches
for disease-specific pathways, gene signatures, micro-
RNA targets, and network modules, by integrating gene-
set-based prior knowledge as molecular patterns from
multiple levels–the genome, transcriptome, post-tran-
scriptome, and proteome. The new database can provide
the following benefits to biological researchers. First, the
new database consists of disease-gene association data,
curated and integrated from Online Mendelian Inheri-
tance in Man (OMIM) [14] database and the Genetic
Association Database (GAD) [15]; therefore, it has the
potential to assist human disease studies. Second, as of
March 2012 it also contains all current compiled gene
signatures in Molecular Signatures Database (MSigDB)
[8] and Gene Signatures Database (GeneSigDB) [7].
Third, it further integrates with microRNA-targets from
miRecords [16] database, signaling pathways, protein
interaction networks, and transcription factor/gene regu-
latory networks, partially based on data integrated from
the Human Pathway Database (HPD) [12] and the
Human Annotated and Predicted Protein Interaction
(HAPPI) [17] database. All gene sets or pathways are
annotated with molecular interaction details whenever
available. We integrated the following version of the
database OMIM [14] (Feb. 2012), GAD [15] (Aug.
2011), GeneSigDB [7] (v. 4.0, Sept. 2011), MSigDB [8]
(v. 3.0. Sept. 2010), HPD [12] (2009), HAPPI [17](v. 1.4)
and miRecords [16] (Nov. 2010), which are the latest
versions available. An advantage of our work lies in its
representation of relationships between pathways, gene
signatures, microRNA targets, and/or network modules.
These gene-set-based relationships can be visualized as
a gene-set association network (GSAN), which provides
a “roadmap” for molecular phenotype discovery for spe-
cific human diseases. Using colorectal cancer expression
data analysis as a case study, we demonstrate how to
query PAGED to discover crucial pathways, gene signa-
tures, and gene network modules specific to colorectal
cancer functional genomics.
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Methods
Data sources
We show an overview of the data integration process in
Figure 1. Gene-set data were collected, extracted, and
integrated from five major categories. The pathway data
sources were from HPD [12], which has integrated 999
human biological pathway data from five curated
sources: KEGG, PID, BioCarta, Reactome, and Protein
Lounge. The genome-level disease gene relationships
were from OMIM [14] and GAD [15]; the transcrip-
tome-level gene signatures were from MSigDB [8] and
GeneSigDB [7]; the post-transcriptome-level microRNA
data were from miRecords [16]; and the proteome level
data was from an integrated protein interaction database
HAPPI [17], which has integrated HPRD, BIND, MINT,
STRING, and OPHID databases.
Gene-set data integration
We treat as gene sets all groups of genes, including dis-
ease-associated genes, pathway genes, gene signatures,
microRNA-targeted genes, and PPI sub-network mod-
ules. The raw files from those data sources have various
formats including plaintext, XML, and table. We have
written Perl/Java parsers to convert them into a com-
mon tab-delimited textual format to ensure syntactic-
level data compatibility. To integrate across different
databases, we mapped the gene/protein IDs in all data-
bases to official gene symbols. The gene-set gene data is
Figure 1 An overview of the gene-set data integration process. The figure shows the whole process of gene-set data integration and the
basic statistics applied to gene-set data sources.
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stored in our backend ORACLE11g relational database.
As of the current release, PAGED contained a total of
25,242 gene sets, 61,413 genes, 20 organisms, and
1,275,560 records. All gene set members are represented
by the official gene symbols. All PAGED gene sets were
assigned unique PAGED-specific identifiers.
Online software designing
The PAGED platform follows a multi-tiered design archi-
tecture. The backend was implemented as PL/SQL
packages on an Oracle 11g database server and the
PAGED application middleware was implemented on the
Oracle Application Express (APEX) server, which bridged
between the Apache webserver and the Oracle database
server.
Gene-set similarity measurement
Referring to the pathway similarity definition introduced
in [12], the similarity score Si, j of two different gene
sets is defined by the following formula:
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Here, Pi and Pj denote two different gene sets, while |Pi|
and |Pj| are the number of genes in each of these two gene
sets. Their intersection Pi∩Pj denotes a common set of
genes, while their union Pi∪Pj is calculated as |Pi| + |Pj| - |
Pi∩Pj|. Here, a is a weight coefficient among [0, 1], which
is used to count varying degree of contributions from cal-
culations based both on the overlap (left item SL) and the
cover (right item SR). SL is well-known as the Jaccard coeffi-
cient [18], which is often used to evaluate the similarity
between two sets [19]. When a larger gene set covers a
smaller one, we expect their similarity score to be high
enough to identify them. In this situation, although the left
item SL is a small number, the right item SR will be
counted as 1.0 to make the final similarity score higher
according to our definition in Equation (1), when taking an
appropriate a value. Additional file 1 shows that how dif-
ferent a value could affect the distribution of the similarity
scores of all cancer related gene sets. We found that when
a fell in the interval of [0.7, 0.9], the score distribution
would be close to a Poisson distribution. As we know, a
Poisson distribution expresses the probability of a number
of events occurring during a fixed period of time if these
events occur with a known average rate and are time-inde-
pendent since the last event. Therefore, we chose the mid-
dle value, a = 0.8, for the rest of the analysis. Our previous
HPD paper [12] also validates the choice of 0.8 as the path-
way similarity measurement.
Microarray data
Here we use colorectal cancer (CRC) expression data
analysis as a case study to show how to discover crucial
pathways, gene signatures, and gene network modules
specific to colorectal cancer functional genomics. We
downloaded a colorectal cancer microarray dataset
GSE8671 from Gene Expression Omnibus, GEO http://
www.ncbi.nlm.nih.gov/geo/[20]. This microarray dataset
compared the transcriptome data of 32 prospectively
collected adenomas with those of the normal mucosa
from the same individuals. Hence, we have 32 CRC
samples and 32 normal samples. We used maximal
expression values for the same proteins mapped from
different Probe IDs, the Affy package in BioConductor
for quantile normalization, the built-in MicroArray Suite
(MAS5) for background correction, and Limma in Bio-
Conductor for differential analysis, the result of which is
represented as fold changes (FC) of CRC samples vs.
normal samples.
Differential gene-set expressions
We use ABS_FC to denote the absolute value of fold
change for each gene. We then define differential gene-
set expressions here as
NORM_ABS_FC: The p*-norm of ABS_FC of all the


















In the implementation, p = 6 performs the best at
accentuating highly differential expressions in a gene set.
Gene-set association network (GSAN) construction
To visualize the relationships between gene sets, we
define a gene-set association network (GSAN) as a net-
work of associations between different gene sets, in
which the network element representation is as follows:
• Node: Gene set
• Edge: Association between two gene sets
• Node size: Gene-set scale (Counting genes in each
gene set)
• Node color: Differential gene-set expression
(NORM_ABS_FC)
• Node line color: Gene-set data source
• Edge width: Similarity score
Results
Database content statistics
Table 1 lists the detailed statistics for each data source
and the overlap between each pair. For example,
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MSigDB contains 30,525 genes and GeneSigDB contains
36,791 genes. The number of overlapping genes between
these two databases is 17,209. We found a synergistic
effect from integrating these two signature databases,
resulting in greatly increased gene-set coverage.
The same effect was observed for all the remaining pair
comparisons. These data sources proved to be
complementary.
Gene-set scale distributions
The gene-set scale can reflect the integrality of informa-
tion content of a biological topic. In this study, we define
gene-set scale as the number of molecules (i.e., gene sym-
bols) in a gene set. We performed a statistical analysis of
the gene-set scale distributions of both PAGED and of its
individual data sources. Figure 2 shows that each data
source taken by itself is not very scale-free, especially for
OMIM, GAD, and miRecords for higher scales and HPD,
GeneSigDB, and MSigDB for lower scales. The scale dis-
tribution of PAGED is relatively scale-free on both the
low end and the high end with a linear regression
R-squared of 0.88. Additionally, the distribution of
PAGED always lies above those of its data sources, indi-
cating that the integration has enriched the number of
gene sets in all scales instead of exhibiting a bias towards
one particular scale. These observations indicate that the
integration process of PAGED has resulted in a database
that can take account of different gene set scales.
Online functionalities
In Figure 3, we show the user interfaces of the PAGED
website. It supports both disease-based search and user-
defined gene-list search. If users search the disease term
in the home page (Figure 3A), PAGED will retrieve a list
of related gene sets by directly matching the disease term
with all the gene-set names; if users instead search a dis-
ease term in the advanced search page (Figure 3D),
PAGED will first retrieve disease-relevant genes from
OMIM and GAD and then use those genes to query the
whole database, which will retrieve a gene-set list based
Table 1 Number of overlapping genes between different data sources
OMIM GAD MSigDB GeneSigDB miRecords HPD HAPPI*
OMIM 9012 1862 3489 2792 231 2559 3849
GAD 7293 6821 6450 432 3202 4922
MSigDB 30525 17209 759 6229 10677
GeneSigDB 36791 900 5904 10395
miRecords 1395 443 725
HPD 12228 10512
HAPPI 21955
* Only PPIs of over 3-star quality are considered here; to calculate the overlap, protein IDs from HAPPI have been first converted to gene symbols.
Figure 2 Gene-set scale distributions for PAGED molecule data. A gene-set scale refers to the number of molecules (i.e., genes) involved in
a given gene set. The frequency on the y-axis refers to the count of all gene sets falling into the category of a particular gene-set scale size on
the x-axis. The distributions are plotted under log scale for both the x-axis and y-axis. The linear trend line in red represents linear regression of
PAGED distribution and the linear equation and its R-Square are listed.
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Figure 3 An overview for the core functionality of the online PAGED website. (A) The PAGED home page providing search by either
disease name or gene list; (B) a webpage containing the list of gene sets retrieved as a result of a disease query; (C) a webpage containing the
list of gene sets retrieved as a result of a gene list query; (D) an advanced search page in which the user can either search disease name or
upload a gene-list to search; (E) a browse page listing the gene sets, their data source and number of genes.
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on disease gene profiles that is more comprehensive than
that of either OMIM or GAD individually. Users can also
search PAGED using multiple genes in the home page
(by delimiting them with a comma) to retrieve a list of
related gene sets with the hits number and similarity
scores (Figure 3A). In addition, users can upload a file of
their genes with one gene per line on the advanced
search page (Figure 3D) to perform the gene-based
search. In the advanced gene-based search (Figure 3D),
user can also perform an organism specific search though
the majority of the gene-sets are human related. All the
gene sets are hyperlinked to the original database, where
user can further examine the detailed annotations of that
specific gene set.
Upon executing the queries, PAGED can retrieve a list
of related gene sets in an HTML table (Figure 3B, C)
with their specific organism information included, which
are downloadable as a comma-separated value (CSV)
file. On the same page, there are links for downloading
all the genes in those gene sets and the association
between each gene set. In the gene set association
downloading page, a simple heat map is provided for
the visualization of gene set similarities. More sophisti-
cated visualization will be provided in the near future.
Case studies
The following case studies use colorectal cancer expres-
sion data analysis as a case study to demonstrate how to
discover crucial pathways, gene signatures, and gene
network modules specific to colorectal cancer functional
genomics.
Case study I: Searching disease-associated gene sets based
on gene-set names
Using the standard query box provided at the PAGED
home page, one can search for colorectal cancer in all
biological gene sets. PAGED returns a list of gene sets,
which can be ordered by decreasing number of genes
contained by each gene set. In total, 45 gene sets from
three data sources (i.e., OMIM, GAD and KEGG) have
been retrieved. Not surprisingly, most of them are dis-
ease-related gene sets from either OMIM or GAD. Only
1 (i.e., “Colorectal cancer pathway”) out 45 is from
KEGG. The top 10 search results are listed in Table 2.
Case study II: Searching disease-associated gene sets based
on gene-set components
Next, a user can search with the same term colorectal
cancer on the advanced search page, which uses the dis-
ease’s gene profile to search for gene sets. PAGED first
obtained 203 colorectal cancer related genes from
OMIM and GAD. Then, it used those genes to retrieve
a total of 4,932 gene sets with at least 2 hits. Since we
are more interested in gene sets other than disease
terms, we excluded those gene sets from OMIM and
GAD for further analysis. To rule out the possibility
that those gene sets were hit randomly, we did a Fisher’s
exact test to calculate the p-value between those 203
genes and every retrieved gene set. Finally, we obtained
3,879 gene sets with a p-value < 0.05 and hits ≥2. These
gene sets are from all data sources, including MSigDB,
GeneSigDB, miRecords, and all pathway data sources
from HPD. Both the number of gene sets and their vari-
ety support the conclusion that advanced disease search
based on gene profiles are more comprehensive than a
simple disease search.
Table 3 shows the top results ranked by decreasing
number of hits from each data source. Protein Lounge
suggests “Molecular Mechanisms of Cancer,” “Akt Signal-
ing,” and other important pathways in colorectal cancer;
BioCarta suggests “wnt signaling pathway"; and NCI Nat-
ure curated suggests “Canonical Wnt signaling pathway.”
These are all very important pathways in colorectal cancer
development [21]. Similarly, “Colorectal cancer” and “p53
signaling pathway” from KEGG, “SIGNAL_TRANSDUC-
TION” and “KEGG_PATHWAYS_IN_CANCER” from
MSigDB, and cancer-related signatures/microRNA from
GeneSigDB/miRecords from Table 3 reveal a comprehen-
sive picture of the important gene sets involved in colorec-
tal cancer. Thus, the results of the advanced search yield
more insights about colorectal cancer mechanisms than
those of the simple search.
Case study III: Searching gene sets similar to user-defined
query gene sets
To use the gene-based search from PAGED, we first ana-
lyzed a colorectal cancer microarray dataset GSE8671 with
BioConductor to identify the differential genes. We
selected the top 100 genes ranked by the absolute fold
change with p-values less than 0.05. After querying
PAGED with those 100 genes, we obtained 1,707 gene
sets, out of which 1,152 also satisfied Fisher’s exact test of
a p-value less than 0.05. Those gene sets span from all the
data sources except BioCarta and miRecords. Table 4 lists
the top results ranked by the number of hits. Most of
Table 2 Top 10 search results by querying colorectal
cancer at the home page




colorectal cancer 433 GAD
Colorectal cancer 134 KEGG
Colorectal cancer 14 OMIM
Colorectal cancer, somatic 12 OMIM
Colorectal cancer, hereditary non-polyposis,
type 8
7 OMIM
Colorectal cancer, susceptibility to 7 OMIM
Colorectal cancer, hereditary non-polyposis,
type 6
6 OMIM
Breast and colorectal cancer, susceptibility to 5 OMIM
Colorectal Cancer 5 GAD
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them are cancer-related gene sets. Specifically, “SABA-
TES_COLORECTAL_ADENOMA_DN” and “SABATES_-
COLORECTAL_ADENOMA_UP” from MSigDB and
“Intestine_Vecchi07_1024genes” and “Colon_Kim04_235-
genes” from GeneSigDB supports the importance of those
100 query genes to colorectal cancer. This case study also
shows the complementary nature of MSigDB and
GeneSigDB and thus the benefit of integrating them,
which has also been proved by [22]
Case study IV: Building disease-specific gene-set association
networks (GSANs) based on gene-set similarities
With the unique top 50 gene sets related to colorectal
cancer from disease search and gene search (Table 3 and
Table 4), we next investigated the gene-set associations
Table 3 Top search results of colorectal cancer advanced search
Gene-set Name Hits P value FDR Data Source
Molecular Mechanisms of Cancer 38 2.48E-17 7.04E-10 Protein Lounge
PI3K Signaling 33 2.01E-13 7.04E-10 Protein Lounge
Akt Signaling 27 9.6E-13 7.04E-10 Protein Lounge
ERK Signaling 24 1.53E-10 7.04E-10 Protein Lounge
GSK3 Signaling 23 1.32E-13 7.04E-10 Protein Lounge
inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages 9 3.7E-11 7.04E-10 BioCarta
atm signaling pathway 8 6.28E-11 7.04E-10 BioCarta
wnt signaling pathway 7 7.7E-09 7.04E-10 BioCarta
cell cycle: g2/m checkpoint 7 2.14E-08 7.04E-10 BioCarta
cell cycle: g1/s check point 7 2.14E-08 7.04E-10 BioCarta
Canonical Wnt signaling pathway 8 9.24E-10 7.04E-10 NCI-Nature
Presenilin action in Notch and Wnt signaling 8 3.16E-08 7.04E-10 NCI-Nature
Plasma membrane estrogen receptor signaling 7 1.41E-08 7.04E-10 NCI-Nature
FOXM1 transcription factor network 7 2.48E-07 7.04E-10 NCI-Nature
LPA receptor mediated events 7 1.45E-06 7.04E-10 NCI-Nature
Metabolism of xenobiotics by cytochrome P450 20 3.3E-25 7.04E-10 KEGG
Drug metabolism - cytochrome P450 17 4.96E-21 7.04E-10 KEGG
Bladder cancer 15 3.29E-18 7.04E-10 KEGG
Cytokine-cytokine receptor interaction 15 1.39E-06 7.04E-10 KEGG
Colorectal cancer 14 4.43E-14 7.04E-10 KEGG
p53 signaling pathway 14 4.92E-14 7.04E-10 KEGG
Prostate cancer 14 1.66E-12 7.04E-10 KEGG
Xenobiotics 5 3.32E-08 7.04E-10 Reactome
Formation of incision complex in GG-NER 5 5.75E-06 7.04E-10 Reactome
Global Genomic NER (GG-NER) 5 5.75E-06 7.04E-10 Reactome
Dual incision reaction in GG-NER 5 5.75E-06 7.04E-10 Reactome
Exocytosis of Alpha granule 5 0.000217 1.95E-08 Reactome
SIGNAL_TRANSDUCTION 55 8.36E-28 7.04E-10 MsigDB
BIOPOLYMER_METABOLIC_PROCESS 49 4.16E-22 7.04E-10 MsigDB
KEGG_PATHWAYS_IN_CANCER 43 9.9E-46 7.04E-10 MsigDB
NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_NUCLEIC_ACID_METABOLIC_PROCESS 41 2.16E-20 7.04E-10 MsigDB
NUCLEUS 41 1.8E-18 7.04E-10 MsigDB
Immune_Kong10_5640genes_ImmPort_ComprehensiveListofImmune-RelatedGenes 114 3.61E-49 7.04E-10 GeneSigDB
Lymphoma_Melendez05_4229genes 81 1.57E-39 7.04E-10 GeneSigDB
Breast_Farmer05_3198genes_basal_apocrine_luminal 66 1.08E-21 7.04E-10 GeneSigDB
Ovarian_Crijns09_2394Genes_17PathwayPredictor 57 7.94E-30 7.04E-10 GeneSigDB
StemCell_Nilsson07_3742genes 45 4.86E-07 7.04E-10 GeneSigDB
hsa-miR-19a 3 1.49E-05 8.43E-09 miRecords
[hsa-miR-21] 3 0.000116 8.43E-09 miRecords
hsa-miR-204 3 0.000164 1.95E-08 miRecords
hsa-miR-21 3 0.000953 2.72E-07 miRecords
hsa-miR-125b 3 0.003089 2.72E-07 miRecords
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between them; 863 associations were found by overlap-
ping the gene symbols between each pair of gene sets,
out of which 642 also satisfied Fisher’s exact test of a p-
value and FDR less than 0.05. A network visualization
using Cytoscape [23] is shown in Figure 4. Most of those
gene sets are connected to one another, and a few share a
large number of genes, suggesting that they form a colla-
borative unit in colorectal cancer.
Table 4 Top search results of gene-based search from microarray datasets
Gene-set Name Hits P value FDR Data Source
SABATES_COLORECTAL_ADENOMA_DN 58 4.57E-96 2.76E-10 MsigDB
Breast_Farmer05_3198genes_basal_apocrine_luminal 35 2.91E-13 2.76E-10 GeneSigDB
SABATES_COLORECTAL_ADENOMA_UP 34 1.62E-57 2.76E-10 MsigDB
Immune_Kong10_5640genes_ImmPort_ComprehensiveListofImmune-RelatedGenes 34 3.56E-08 2.76E-10 GeneSigDB
Leukemia_Pellegrini08_2692genes 32 1.28E-15 2.76E-10 GeneSigDB
Intestine_Vecchi07_1024genes 28 3.91E-23 2.76E-10 GeneSigDB
Viral_Buonomo11_5307genes 25 6.45E-05 0.000109 GeneSigDB
SMID_BREAST_CANCER_LUMINAL_B_DN 23 4.16E-19 2.76E-10 MsigDB
Lymphoma_Melendez05_4229genes 22 2.03E-06 2.76E-10 GeneSigDB
Colon_Kim04_235genes 21 5.18E-30 2.76E-10 GeneSigDB
Breast_Parker09_1918genes_IntrinsicGenes_Compilation 21 1.18E-08 2.76E-10 GeneSigDB
Figure 4 CRC-specific gene-set association network (GSAN) on the top gene sets from colorectal cancer study. Node size: Gene-set scale
(Counting genes in each gene set); Node color: Gene-set data source; Edge width: Similarity score (≥ 0.1). All gene sets are highly connected to
each other, suggesting their collaborative functions in colorectal cancer.
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Case study V: Prioritizing disease-associated gene sets by
using differential gene-set expressions
First, the differential gene expression value (ABS_FC) for
each gene in a gene set is calculated from the differential
analysis based on the microarray data GSE8671. Second,
the differential gene-set expression value (NOR-
M_ABS_FC) for each gene set in the CRC-specific GSAN
is calculated by using Equation (2). Third, a CRC-specific
GSAN with differential gene-set expressions is shown in
Figure 5, in which node size represents gene-set scale
(Counting genes in each gene set); node color represents
differential gene-set expression (NORM_ABS_FC); node
line color represents the gene-set data source; and edge
width represents the similarity score. By considering differ-
ential gene-set expressions for each gene set, we prioritize
top-selected gene sets as shown in Table 5. Most of top-
ranked gene sets are closely related to colon tissue, color-
ectal cancer, or other cancers, which implies that our
database can not only support comprehensive disease-
associated gene-set searching and browsing, but also accu-
rate, disease-specific gene-set prioritizing by using the
concept of differential expressions at the gene-set level.
Discussion
In the near future, we will improve gene-set similarity
algorithms by using a global PPI network to calculate
their distance. This would provide a more robust mea-
surement for web interface development, and we plan to
add a disease browsing function based on disease ontol-
ogy and a network visualization function to show the
gene-set association dynamically. Our final goal is to per-
form multi-scale network modeling for molecular pheno-
type discoveries by integrating differential expressions
with pathway and network topologies. The current
release of PAGED provides a solid foundation for us to
develop third-generation pathway analysis tools [1].
Figure 5 CRC-specific gene-set association network (GSAN) with differential gene-set expressions. The differential gene expressions are
from the differential analysis based on the microarray data, GSE8671. Node size: Gene-set scale (Counting genes in each gene set); Node color:
Differential gene-set expression (NORM_ABS_FC); Node line color: Gene-set data source; and Edge width: Similarity score (≥ 0.1).
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Conclusions
We developed PAGED, an online database that provides
the most comprehensive public compilation of gene sets.
In the current release, PAGED contains a total of 25,242
gene sets, 61,413 genes, 20 organisms, and 1,275,560
records from five major categories: the pathway data
from HPD, genome-level disease data from OMIM and
GAD, transcriptome-level gene signatures from MSigDB
and GeneSigDB, the post-transcriptome microRNA data
from miRecords, and proteome-level data from HAPPI.
The number of overlapping genes between each data
source, gene-set scale distribution, and case study in col-
orectal cancer shows the synergistic effect of integrating
data sources, which greatly facilitate access to gene-set-
based prior knowledge. The current PAGED software
can help users address a wide range of gene-set-related
questions in human disease biology studies.
Additional material
Additional file 1: Change of similarity score with different a in
Equation I. The frequency on the y-axis refers to the count of all gene
set pairs falling into the category of a particular similarity range on the x-
axis. Different a in Equation I have been used to calculate the similarity
score. When a approaches 0, the distribution skewed to right with many
false positive high similarity scores; when a approach 1, the distribution
is too left-skewed failing to differentiate those low similarity scores apart.
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Table 5 Top 20 gene sets ranked by differential gene-set expressions in the CRC-specific gene-set association network
(GSAN)
Gene-set name Scale Data Source NORM_ABS_FC
Colon_Kim04_235genes 151 GeneSigDB 48.58225017
SABATES_COLORECTAL_ADENOMA_DN 292 MsigDB 43.9233159
SIGNAL_TRANSDUCTION 1598 MsigDB 32.5957784
Leukemia_Pellegrini08_2692genes 2122 GeneSigDB 31.65148925
SABATES_COLORECTAL_ADENOMA_UP 142 MsigDB 31.65000681
Breast_Parker09_1918genes_IntrinsicGenes _Compilation 1734 GeneSigDB 20.85621131
Lymphoma_Melendez05_4229genes 2570 GeneSigDB 19.38449282
Breast_Farmer05_3198genes_basal _apocrine _luminal 3125 GeneSigDB 18.93820407
SMID_BREAST_CANCER_LUMINAL_B_DN 648 MsigDB 18.13762096
Intestine_Vecchi07_1024genes 796 GeneSigDB 16.68882931
Ovarian_Crijns09_2394Genes _17PathwayPredictor 1586 GeneSigDB 15.29529767
hsa-miR-204 19 miRecords 14.37015815
StemCell_Nilsson07_3742genes 3624 GeneSigDB 12.47045771
Immune_Kong10_5640genes_ImmPort _ComprehensiveListofImmune-RelatedGenes 4549 GeneSigDB 11.91186233
cell cycle: g1/s check point 53 BioCarta 9.84279867
Bladder cancer 89 KEGG 7.885181064
Drug metabolism - cytochrome P450 94 KEGG 7.837851592
Metabolism of xenobiotics by cytochrome P450 103 KEGG 7.837805455
hsa-miR-21 34 miRecords 7.001844224
KEGG_PATHWAYS_IN_CANCER 328 MsigDB 6.792625895
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